Ampersand Capital Partners Achieves Top Ranking in Private Equity
Once again, Ampersand Capital Partners has secured a prestigious position as the top growth capital private equity firm globally, as announced by HEC Paris–Dow Jones. This recognition marks the third year in a row that the firm has captured this distinguished title, showcasing its commitment to excellence in the healthcare investment sector.
Commitment to Excellence
Herb Hooper, Managing Partner at Ampersand Capital Partners, expressed pride in this achievement, stating, “This recognition underscores the dedication and expertise of our investment team.” The firm’s unwavering focus on the healthcare industry, combined with the exceptional performance of its portfolio companies, has significantly contributed to maintaining this outstanding track record.
Analysis of Global Competition
The annual ranking, spearheaded by Professor Oliver Gottschalg of HEC Paris in collaboration with Dow Jones, scrutinized the performance of an impressive array of 278 growth capital firms and 505 funds raised between 2011 and 2020. The total equity volume analyzed amounted to a staggering $329 billion. Despite intensifying global competition, with new entrants from the UK and Japan breaking into the Top 10, Ampersand has successfully held its ground, demonstrating remarkable and consistent leadership.
Methodology and Insights
The insights from the report, which was based on extensive data gathering through late 2024, illustrate the dynamic nature of the global growth capital landscape. Private equity firms continue to adapt and innovate, driven by competition and evolving market demands. Ampersand’s success is a testament to its strategic vision and operational excellence.
A Look at Ampersand Capital Partners
Established in 1988, Ampersand Capital Partners has become a key player in middle-market private equity. With approximately $3 billion in assets under management, the firm focuses on fostering growth in the healthcare sector. Its dual-office presence in Boston and Amsterdam allows Ampersand to leverage a rich combination of private equity acumen and operational proficiency, helping to propel its portfolio companies to the forefront of their respective markets.
Investing in the Future
The firm has been instrumental in building several market-leading enterprises across various core healthcare sectors. By partnering closely with management teams, Ampersand ensures that each investment is positioned for long-term growth and stability. The combination of robust management strategies and a deep understanding of market trends places Ampersand in an enviable position within the private equity landscape.
Conclusion
As Ampersand Capital Partners continues to thrive and evolve within the competitive realm of private equity, their consistent performance and dedication to their portfolio's success exemplify what it means to be a leader in the industry. With a clear focus on healthcare and an ongoing commitment to excellence, the firm is poised for future success and growth.
Frequently Asked Questions
What accolade has Ampersand Capital Partners recently achieved?
Ampersand Capital Partners has been ranked #1 globally for growth capital private equity performance for three consecutive years by HEC Paris-Dow Jones.
Who leads the HEC Paris-Dow Jones ranking?
The ranking is led by Professor Oliver Gottschalg of HEC Paris in collaboration with Dow Jones.
What is Ampersand Capital Partners’ primary area of investment?
Ampersand primarily focuses on growth-oriented investments within the healthcare sector.
How long has Ampersand Capital Partners been established?
Ampersand Capital Partners was founded in 1988, making it a seasoned player in the private equity space.
Where are the offices of Ampersand Capital Partners located?
The firm has offices in Boston, MA, and Amsterdam, Netherlands.
